Filing Details
- Accession Number:
- 0001203311-12-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-10-02 21:23:22
- Reporting Period:
- 2012-10-01
- Filing Date:
- 2012-10-02
- Accepted Time:
- 2012-10-02 20:23:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-10-01 | 6,250 | $3.30 | 1,177,211 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-10-01 | 6,250 | $26.59 | 1,170,961 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-10-01 | 2,000 | $10.33 | 1,172,961 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-10-01 | 2,000 | $26.59 | 1,170,961 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-10-01 | 6,250 | $0.00 | 6,250 | $3.30 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-10-01 | 2,000 | $0.00 | 2,000 | $10.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,749 | 2004-01-31 | 2013-01-31 | No | 4 | M | Direct |
| 29,858 | 2005-01-30 | 2014-02-17 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Siegall and described in a Form 8-K filed on June 15, 2012.
- 26.5872 represents an average price per share for the shares sold on 10/1/2012. The sell price for shares sold on this day ranged from $26.3750 to $27.28.
- Amount of securities beneficially owned following reported transactions includes 152,387 Restricted Stock Units subject to vesting.
- 25% of the shares vested on 1/31/04. The remainder vested monthly thereafter until all shares were fully vested on 1/31/07.
- 25% of the shares vested on 1/20/05. The remainder vested monthly thereafter until all shares were full vested on 1/30/08.
Billionaire Hedge Funds
